Novo Nordisk A/S

Industry / private company

Kopenhagen (Copenhagen), Denmark

Research projects with FAU researchers

(Advanced Computed Tomography for dimensional and surface measurements in industry):
AdvanCT: Advanced Computed Tomography for dimensional and surface measurements in industry
Prof. Dr.-Ing. Tino Hausotte
(01/06/2018 - 31/05/2021)
(Multi-sensor metrology for microparts in innovative industrial products):
Microparts: Multi-sensor metrology for microparts in innovative industrial products
Prof. Dr.-Ing. Tino Hausotte
(01/09/2013 - 31/05/2016)

Publications in cooperation with FAU scientists

Nauck, M.A., Buse, J.B., Mann, J., Pocock, S., Bosch-Traberg, H., Frimer-Larsen, H.,... Gray, A. (2019). Health-related quality of life in people with type 2 diabetes participating in the LEADER trial. Diabetes Obesity & Metabolism, 21(3), 525-532.
Husain, M., Bain, S.C., Mann, J., Nauck, M., Poulter, N., Baeres, F.M.M.,... Marso, S. (2018). Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events. In EUROPEAN HEART JOURNAL (pp. 490-490). Munich, GERMANY: OXFORD: OXFORD UNIV PRESS.
Tuncel, J., Haag, S., Hoffmann, M., Yau, A.C.Y., Hultqvist, M., Olofsson, P.,... Holmdahl, R. (2016). Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat. PLoS ONE, 11(5), e0155936.
Petrie, J.R., Marso, S.P., Bain, S.C., Franek, E., Jacob, S., Masmiquel, L.,... Poulter, N.R. (2016). LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial. Journal of Hypertension, 34(6), 1140-50.
Marso, S.P., Daniels, G.H., Brown-Frandsen, K., Kristensen, P., Mann, J., Nauck, M.A.,... Buse, J.B. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 375(4), 311-22.
Daniels, G.H., Hegedus, L., Marso, S.P., Nauck, M.A., Zinman, B., Bergenstal, R.M.,... Tuttle, M. (2015). LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. Diabetes Obesity & Metabolism, 17(5), 477-86.

Last updated on 2015-09-12 at 12:14